Comparative trial of 3 days of azithromycin versus 10 days of clarithromycin in the treatment of children with acute otitis media with effusion

Journal of Chemotherapy

Volumn 9, Issue 1, 1997, Pages 44-50

  Arguedas, A ^a,b   Loaiza, C ^a   Rodriguez, F ^a   Herrera, M L ^a,b   Mohs, E ^a,c  

^a National Children Hospital   (Costa Rica)

^b Univ Autonoma de Cie Medicas   (Costa Rica)

^c UNIVERSIDAD DE COSTA RICA   (Costa Rica)

Author keywords

acute otitis media; azithromycin; clarithromycin

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN;

ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; EFFUSION; HAEMOPHILUS INFLUENZAE; HUMAN; INFANT; MAJOR CLINICAL STUDY; NAUSEA; NEUTROPENIA; ORAL DRUG ADMINISTRATION; OTITIS MEDIA; RANDOMIZED CONTROLLED TRIAL; RASH; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; THROMBOCYTOSIS; VOMITING;

EID: 0030991393     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.1997.9.1.44     Document Type: Article

References (23)

1. Klein JO, Bluestone CD. Acute otitis media. Pediatr Infect Dis 1982;1:66-73.
2. Owen MJ, Baldwin CD, Swank PR, Pannu AK, Johnson DL, Howie VM. Relation of infant feeding practices, cigarette smoke exposure, and group child care to the onset and duranon of otitis media with effusion in the first two years of life. J Pediatr 1993;123:702-711.
3. Berman S, Roark R. Factors influencing outcome in children treated with antibiotics for acute otitis media. Pediatr Infect Dis J 1993;12:20-24.
4. Neu HC. Otitis media: antibiotic resistance of causative pathogens and treatment alternatives. Pediatr Infect Dis J 1995;14:S51-56.
5. Nelson CT, Mason HO, Kaplan SL. Activity of oral antibiotics in middle ear and sinus infections caused by penicillin-resistant Streptococcus pneumoniae: implication for treatment. Pediatr Infect Dis J 1994;13:585-589.
6. Maskell JP, Sefton AM, Williams JD. Comparative invitro activity of azithromycin and erythromycin against Grampositive cocci, Haemophilus influenzae and anaerobes. J Antimicrob Agents Chemother 1990;25(SA):19-24.
7. Hardy DJ, Hensy DM, Beyer JM, Vojtko C, McDonald E, Fernandes PB. Comparative in-vitro activity of new 14-, 15-, and 16-member macrolides. Antimicrob Agents Chemother 1988;32:1710-1719.
8. Nahata MC, Koranyi DI, Gadgil SD, Hilligoss DM, Fouda HG, Gardner MJ. Pharmacokinetics of azithromycin in pediatric patients after oral administration of multiple doses of suspension. Antimicrob Agents Chemother 1993;37:314-316.
9. Foulds GR, Shepar RM, Johnson RB. The pharmacokinetics of azithromycin in human scrum and tissues. J Antimicrob Chemother 1990;25 (SA):73-82.
10. Aspin MM, Hoberman A, McCarty J, McLinn SE, Aronoff S, Lang DJ, Arrieta A. Comparative study of the safety and efficacy of clarithromycin and amoxicillin-clavulanate in the treatment of acute otitis media in children. J Pediatr 1994;125:136-41.
11. Pukander JS, Jero JP, Kaprio EA, Sorri MJI. Clarithromycin vs amoxicillin suspensions in the treatment of pediatric patients with acute otitis media. Pediatr Infect Dis J 1993;12:S118-121.
12. Craft JC, Siepman N. Overview of the safety profile of clarithromycin suspensions in pediatric patients. Pediatr Infect Dis J 1993;12:S142-147.
13. National Committee for Clinical Laboratory Standards. Antimicrobial disk susceptibilities test. Approved standard M2-T4, National Committee for Clinical Laboratory Standards, Villanova, PA, 1988.
14. Arguedas AG, Zaleska M, Stutman HR, Blumer JL, Hains CS. Comparative trial of cefprozil vs. amoxicillin clavulanate potassium in the treatment of children with acute otitis media with effusion. Pediatr Infect Dis J 1991;10:375-380.
15. McCarty JM. Bacterial susceptibility and tympanocentesis in acute otitis media. Pediatr Infect Dis J 1995;14:S45-50.
16. Pichicero ME. Assessing the treatment alternatives for acute otitis media. Pediatr Infect Dis J 1994;13:S27-34.
17. Mohs E, Rodriguez-Solares A, Rivas E, El Hoshy Z. A comparative study of azithromycin and amoxicillin in pediatric patients with acute otitis media. J Antimicrob Chemother 1993;31(SE):73-79.
18. Shaad UB. Multicentre evaluation of azithromycin in comparison with co-amoxiclav for the treatment of acute otitis media in children. J Antimicrob Chemother 1993;14:S62-6.
19. McLinn S. Double blind and open label studies of azithromycin in the management of acute otitis media in children: a review. Pediatr Infect Dis J 1995;14:S62-6.
20. Odio CM, Kusmiesz H, Shelton S, Nelson JD. Comparative treatment of Augmentin versus cefaclor for acute otitis media with effusion. Pediatrics 1985;75:819-26.
21. Blumer JL, Bertino JS, Husak MP. Comparison of cefaclor and trimethoprim-sulfamethoxazole in the treatment of acute otitis media. Pediatr Infect Dis J 1984;3:25-29.
22. McLinn SE. Randomized, open label, multicenter trial of cefixime compared with amoxicillin for treatment of acute otitis media with effusion. Pediatr Infect Dis J 1987;6:997-1001.
23. Schentag JJ. Antibiotic treatment of acute otitis media in children: dosing considerations. Pediatr Infect Dis J 1995;14:S30-33.